Evaluation of ADAM-12 as a diagnostic biomarker of ectopic pregnancy in women with a pregnancy of unknown location

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Horne, Andrew W ^a   Brown, Jeremy K ^a   Tong, Stephen ^b   Kaitu'u Lino, Tu'uhevaha ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM 12 PROTEIN; ADAM PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ECTOPIC PREGNANCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY DISORDER; PREGNANCY OF UNKNOWN LOCATION; PREGNANCY OUTCOME; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SPONTANEOUS ABORTION; VIABLE INTRAUTERINE PREGNANCY;

ADAM PROTEINS; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; PREGNANCY; PREGNANCY, ECTOPIC; YOUNG ADULT;

EID: 84865177344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041442     Document Type: Article

References (13)

1. Kirk E, Papageorghiou AT, Condous G, Tan L, Bora S, et al. (2007) The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancy. Hum Reprod 22: 2824-2828.
2. Condous G, Okaro E, Khalid A, Timmerman D, Lu C, et al. (2004) The use of a new logistic regression model for predicting the outcome of pregnancies of unknown location. Hum Reprod 19: 1900-1910.
3. Jurkovic D, Wilkinson H, (2011) Diagnosis and management of ectopic pregnancy. BMJ 342: d3397.
4. Sivalingam VN, Duncan WC, Kirk E, Shephard LA, Horne AW, (2011) Diagnosis and management of ectopic pregnancy. J Fam Plann Reprod Health Care 37: 231-240.
5. Barnhart K, Speicher DW, (2011) Molecular diagnosis of ectopic pregnancy. Expert Rev Mol Diagn 11: 759-762.
6. Wedderburn CJ, Warner P, Graham B, Duncan WC, Critchley HO, et al. (2010) Economic evaluation of diagnosing and excluding ectopic pregnancy. Hum Reprod 25: 328-333.
7. Horne AW, Duncan WC, Critchley HO, (2010) The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy. Acta Obstet Gynecol Scand 89: 299-301.
8. Rausch ME, Beer L, Sammel MD, Takacs P, Chung K, et al. (2011) A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil Steril 95: 1373-1378.
9. Wiwanitkit V, (2011) Disintegrin and metalloprotease and ectopic pregnancy. Fertil Steril 95: e21; author reply e22.
10. Laigaard J, Spencer K, Christiansen M, Cowans NJ, Larsen SO, et al. (2006) ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 26: 973-979.
11. Tørring N, Ball S, Wright D, Sarkissian G, Guitton M, et al. (2010) First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker. Reprod Biol Endocrinol 29 8: 129.
12. Barnhart K, van Mello NM, Bourne T, Kirk E, Van Calster B, et al. (2011) Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil Steril 95: 857-866.
13. Sahraravand M, Järvelä IY, Laitinen P, Tekay AH, Ryynänen M, (2011) The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy. Placenta 32: 999-1003.